Brucellosis: the case for live, attenuated vaccines. (1/192)

Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. (2/192)

Dengue virus serotype 4, northeastern Peru, 2008. (3/192)

Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. (4/192)

Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens. (5/192)

Estimates of the transmissibility of the 1968 (Hong Kong) influenza pandemic: evidence of increased transmissibility between successive waves. (6/192)

Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection. (7/192)

Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need? (8/192)

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10